… have been developed by the tumoral cells against this antibody, such as the decrease of the
… of the CD20 antibody or alterations in the cell membrane. New anti-CD20 antibodies have …

… The anti-CD20 antibody will be formulated for therapeutic usage by standard methods, eg, …
water, propylene glycol, and combinations thereof. Effective dosages will depend on the …

… methods of treating relapsed/resistant non-Hodgkin's lymphoma using combination therapy
with an anti-CD20 antibody … antigen-binding fragment thereof and an anti-CD20 antibody or …

… be more sensitive to change in early RA than methods using … the tumor can be conjugated
to the anti-CD20 antibody such … can be determined by the particular anti-CD20 antibody that …

… be more sensitive to change in early RA than methods using … the tumor can be conjugated
to the anti-CD20 antibody such … can be determined by the particular anti-CD20 antibody that …

… The invention provides hybrid constant regions and antibodies or fusion proteins incorporating
the … carboxyl terminus of the heavy chain in the humanized anti-CD20 IgG1 antibody, …

… a first antibody or fragment thereof that binds to CD74 or HLA… antibody or fragment thereof
that binds to an antigen … two or more antibodies, antibody fragments or fusion proteins which …

… These polypeptides provide several advantages over other FcγR-binding moieties, including
IgG, Fc fragments, IgG fusion proteins, and complexes and/or aggregates thereof. These …

… Rituximab is the first anti-CD20 monoclonal antibody that has changed the management and
… The detection may be made using monoclonal antibodies, any fragments thereof, such as …

… Obinutuzumab is a humanized Type II anti-CD20 antibody that has been glycoengineered
to … Differential binding of anti-CD20 obinutuzumab and mutants thereof to CD20. (A) Surface …